DocGo director receives 150,000 RSUs under stock plan vesting 2026
DocGo Inc. director Etalvina Leite received an equity award in the form of restricted stock units.
Rhea-AI Filing Summary
DocGo Inc. director Etalvina Leite received an equity award in the form of restricted stock units. On December 12, 2025, Leite was granted 150,000 restricted stock units of DocGo common stock at a grant price of $0 under the company’s 2021 Stock Incentive Plan. These RSUs are scheduled to vest on December 12, 2026, and each unit will convert into one share of common stock upon vesting, subject to the plan’s terms. Following this award, Leite beneficially owns 201,411 shares of DocGo common stock, held directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 150,000 | $0.00 | $0.00 |
Footnotes (1)
- F1. Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan") that will vest on December 12, 2026, subject to the terms of the Plan. Each RSU represents the right to receive, upon vesting, one share of Common Stock, subject to the terms of the Plan.
FAQ
What insider transaction did DocGo (DCGO) report for director Etalvina Leite?
DocGo reported that director Etalvina Leite received a grant of 150,000 restricted stock units (RSUs) of DocGo common stock on December 12, 2025.
When do the new DocGo (DCGO) restricted stock units for the director vest?
The 150,000 RSUs granted to director Etalvina Leite are scheduled to vest on December 12, 2026, subject to the terms of DocGo’s 2021 Stock Incentive Plan.
What does each DocGo (DCGO) RSU granted to the director represent?
Each restricted stock unit granted to the director represents the right to receive one share of DocGo common stock upon vesting, in line with the company’s 2021 Stock Incentive Plan.
Under which plan were the DocGo (DCGO) RSUs for the director granted?
The 150,000 RSUs granted to director Etalvina Leite were issued under DocGo’s 2021 Stock Incentive Plan, according to the filing.
AI-generated analysis. How Rhea-AI works. Not financial advice.